Johnson & Johnson announced that it has received European CE Mark approval for its new ETHICON 4000 Stapler, an advanced surgical stapler designed to deliver reliable staple line… read more.
People with insurance through an employer or another commercial plan experienced an average wait time of 50 days for their first visit with a neurology provider, according to… read more.
The Nuffield Department of Women’s & Reproductive Health at the University of Oxford, together with Serac Healthcare Limited announces the publication of Phase 2 data in The Lancet Obstetrics and Gynaecology. The findings highlight the… read more.
The EMA’s CHMP adopted a positive opinion, recommending the granting of a conditional marketing authorisation for the medicinal product Adstiladrin. Since Adstiladrin is an advanced therapy medicinal product, the… read more.
Auburn University researchers have published a study in Current Pharmaceutical Analysis providing critical stability data for a key anesthetic used in camelid medicine. The combination of ketamine, xylazine, and butorphanol… read more.
Abbott announced new late-breaking data at Heart Rhythm Society (HRS) meeting from four trials that demonstrate strong clinical outcomes within its pulsed field ablation (PFA) and conduction system… read more.
Heatwaves and coldwaves are associated with increases in major cardiovascular events that are exacerbated by air pollution.1 Concerning results on the adverse impact of climate change and pollution on… read more.
A cancer diagnosis can upend any life. For young adults already navigating a step into independence, it can be especially distressing. But there are few evidence-based interventions to… read more.
Galderma issued new data from two investigator-initiated trials (IITs), demonstrating the power of Sculptra – the first proven regenerative biostimulator – and the company’s versatile hyaluronic acid injectable… read more.
Speaking today at the 46th Annual Meeting and Scientific Sessions of the International Society for Heart and Lung Transplantation (ISHLT) Jagbir Gill, MD, Associate Professor of Medicine in the Division… read more.
Colorectal cancer (CRC) is the second most common cause of cancer death in the United States and disproportionally impacts people who receive care in under-resourced settings. Fortunately, several… read more.
Bayer announced that the European Commission has granted approval in the European Union (EU) for Kerendia (finerenone), a selective, non-steroidal mineralocorticoid receptor antagonist (nsMRA), for the treatment of… read more.
If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.
You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.
